US sees surge in self-administered peptide use as a wellness trend

The United States is experiencing a rising interest in injectable peptides. Enthusiasts are self‑administering these compounds. Participants liken the practice to being lab rats. The trend reflects a broader wellness craze. Peptides are marketed for various health benefits. Medical experts warn about unregulated use. The surge raises concerns over safety and oversight. Regulators may consider tighter controls.